<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Life sciences briefing: Monday, Aug. 13, 2007</title>
	<atom:link href="http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Sat, 21 Nov 2009 19:27:54 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Wednesday, Nov. 21, 2007</title>
		<link>http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/comment-page-1/#comment-645122</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Wednesday, Nov. 21, 2007</dc:creator>
		<pubDate>Wed, 21 Nov 2007 21:47:56 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/#comment-645122</guid>
		<description>[...] top of its expected per-share range of $27. As we noted earlier &#8212; see our previous coverage here and here &#8212; Reliant is kind of a mixed bag insofar as specialty pharma companies go. It yanked [...]</description>
		<content:encoded><![CDATA[<p>[...] top of its expected per-share range of $27. As we noted earlier &#8212; see our previous coverage here and here &#8212; Reliant is kind of a mixed bag insofar as specialty pharma companies go. It yanked [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Thursday, Nov. 1, 2007</title>
		<link>http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/comment-page-1/#comment-608932</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Thursday, Nov. 1, 2007</dc:creator>
		<pubDate>Thu, 01 Nov 2007 12:42:05 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/#comment-608932</guid>
		<description>[...] Nanosphere is focused on molecular diagnostics that gauge the likelihood of problems such as blood clots or a patient&#8217;s likely response to a particular medication. Our previous coverage of the company is here and here. [...]</description>
		<content:encoded><![CDATA[<p>[...] Nanosphere is focused on molecular diagnostics that gauge the likelihood of problems such as blood clots or a patient&#8217;s likely response to a particular medication. Our previous coverage of the company is here and here. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Thursday, Oct. 18, 2007</title>
		<link>http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/comment-page-1/#comment-585006</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Thursday, Oct. 18, 2007</dc:creator>
		<pubDate>Thu, 18 Oct 2007 17:57:05 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/#comment-585006</guid>
		<description>[...] up from Nanotech&#8217;s initial plan to raise $100 million in the offering, which we wrote about here (seventh item). Either way, it&#8217;s still a fairly princely sum, particularly given that only [...]</description>
		<content:encoded><![CDATA[<p>[...] up from Nanotech&#8217;s initial plan to raise $100 million in the offering, which we wrote about here (seventh item). Either way, it&#8217;s still a fairly princely sum, particularly given that only [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Double vision: Ophthotech, Eyetech and Lux BioSciences</title>
		<link>http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/comment-page-1/#comment-453602</link>
		<dc:creator>VentureBeat &#187; Double vision: Ophthotech, Eyetech and Lux BioSciences</dc:creator>
		<pubDate>Fri, 17 Aug 2007 02:34:05 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/#comment-453602</guid>
		<description>[...] didn&#8217;t write any of this at the time, however, and in the meantime several others have pointed out a number of interesting facts about [...]</description>
		<content:encoded><![CDATA[<p>[...] didn&#8217;t write any of this at the time, however, and in the meantime several others have pointed out a number of interesting facts about [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Thursday, Aug. 16, 2007</title>
		<link>http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/comment-page-1/#comment-449010</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Thursday, Aug. 16, 2007</dc:creator>
		<pubDate>Thu, 16 Aug 2007 16:39:25 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/#comment-449010</guid>
		<description>[...] days after Reliant Pharmaceuticals filed for a $400 million initial offering (see our coverage in this daily briefing). That should certainly keep investors on their toes. Journalists, too &#8212; I almost [...]</description>
		<content:encoded><![CDATA[<p>[...] days after Reliant Pharmaceuticals filed for a $400 million initial offering (see our coverage in this daily briefing). That should certainly keep investors on their toes. Journalists, too &#8212; I almost [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Hair-transplant automator Restoration Robotics raises $25M</title>
		<link>http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/comment-page-1/#comment-423124</link>
		<dc:creator>VentureBeat &#187; Hair-transplant automator Restoration Robotics raises $25M</dc:creator>
		<pubDate>Mon, 13 Aug 2007 22:22:44 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/13/life-sciences-briefing-monday-aug-13-2007/#comment-423124</guid>
		<description>[...] systems for hair transplants, raised $25 million in a second round of funding. See our story in the daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] systems for hair transplants, raised $25 million in a second round of funding. See our story in the daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
